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SUMMARY
Complex segregation analysis with the unified mixed model in white
families from nine lipid research clinics was carried out to delineate
the mode of familial transmission of plasma high-density-lipoprotein
cholesterol (HDL-C). Three groups of families from the collaborative
Lipid Research Clinics Program Family Study were assessed: 1,146
selected at random, 483 obtained through hypercholesterolemic pro-
bands, and 177 selected from the random sample because a number
had low HDL-C, the sample sizes being 4,279, 1,807 and 735, respec-
tively. The data were first transformed and adjusted for effects of
covariates. Analyses were performed within clinic and selection strata
and also pooled across clinics within strata. The results were consis-
tent across strata and identified two major HDL-C clusters with
means separated by -3 SD. There was significant evidence of trans-
mission of a major factor for low HDL-C, but transmission did not
conform to Mendelian segregation expectations. There was also evi-
dence of significant multifactorial transmission. Since low HDL-C
levels are a major independent risk factor for coronary heart disease,
the association of a major factor with familial aggregation of low
HDL-C emphasizes the importance of detailed within-family sampling
for low HDL-C after identifying a proband whose predominant dys-
lipoproteinemia is low HDL-C.
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INTRODUCTION
Low levels of high-density-lipoprotein cholesterol (HDL-C) are associated with
increased mortality from coronary heart disease and cardiovascular disease
(Miller and Miller 1975; Castelli et al. 1977; Gordon et al. 1977; Goldbourt and
Medalie 1979), particularly at older ages, and increased evidence of arterio-
graphically defined coronary artery disease at all ages (Pearson et al. 1979).
This is generally true in both sexes, even after adjustment for other coronary
risk factors, such as age, other cholesterol components, smoking, high blood
pressure, obesity, and diabetes. There is also evidence that increased levels of
HDL-C are associated with longevity (Glueck et al. 1975, 1976, 1977).
There is significant familial aggregation of HDL-C levels-with a correlation
between first-degree relatives of -0.2-0.3-and very small correlations be-
tween spouses (see Namboodiri et al. 1983 for review). The heritability esti-
mated from path analysis is -0.40 in diverse populations, with a smaller but
still significant component accounted for by cultural inheritance (Iselius 1979;
Rao et al. 1979, 1982; Namboodiri et al. 1985). There is also consistent evidence
from several studies that HDL-C levels are lower in first-degree relatives of
myocardial infarction patients as compared with those in relatives of controls
(Micheli et al. 1979; Nupuf and Sutherland 1979; Pometta et al. 1979, 1980).
The question of whether there is a single locus that significantly influences
HDL-C levels has recently received considerable attention (Morton et al. 1978;
Siervogel et al. 1980; Vergani and Bettale 1981; Iselius and Lalouel 1982;
Malloy and Kane 1982; Rao et al. 1983; Byard et al. 1984; Hasstedt et al. 1984;
Third et al. 1984; Borecki et al. 1986). Several studies have investigated the
mode of inheritance of elevated HDL-C levels (Glueck et al. 1975, 1977; Sier-
vogel et al. 1980; Iselius and Lalouel 1982; Malloy and Kane 1982; Rao et al.
1983); these studies have suggested the likelihood of a major effect that does
not appear to be due to a major gene.
There are rare syndromes marked by extremely low or absent HDL-C (e.g.,
Tangier disease) that are probably due to an autosomal recessive gene
(Fredrickson et al. 1961, 1964). The inheritance of less severe hypoalphalipo-
proteinemia, often defined as HDL-C below the tenth percentile of a control
population (Third et al. 1984), has also been investigated. Byard et al. (1984),
Third et al. (1984), and Borecki et al. (1986) have found evidence of a major
locus for low HDL-C in families ascertained through probands with low HDL-
C. Hasstedt et al. (1984), however, have found significant evidence of a mul-
tifactorial component but no evidence of a major locus in a large pedigree
ascertained through multiple cases of myocardial infarction; however, in a
subsequent analysis of pedigrees ascertained for several cardiovascular-disease
end points, they have reported a dominant major gene effect for low HDL-C
(Hasstedt et al. 1986).
The purpose of the present report is to investigate the transmission of low
HDL-C levels by using the large data base of the Lipid Research Clinics Pro-
gram Family Study. These data contain a randomly selected component, as
well as families ascertained through probands with elevations of total choles-
490 BUCHER ET AL.
HIGH-DENSITY LIPOPROTEIN CHOLESTEROL
terol and/or triglycerides. This will allow us to investigate the inheritance of
low HDL-C levels in several population segments with a large sample size.
MATERIAL AND METHODS
The Lipid Research Clinics Program Family Study was conducted in nine
North American clinics during 1975-78 as the third phase of the Lipid Research
Clinics Program's population surveys. The details of the study design and
general characteristics of the data have been reported elsewhere (Family Study
Committee 1984; Namboodiri et al. 1984). In brief, the first phase, Visit 1 (VI)
was a population-based screening of >56,000 subjects from different target
populations. Levels of total cholesterol and triglycerides and selected demo-
graphic characteristics were gathered during this screening. A 15% random
sample and a hyperlipidemic sample were recalled for a second screening (V2).
Complete lipoprotein quantification; medical and medication histories; dietary,
anthropometric and blood-pressure data, and graded exercise tests; and several
ancillary biochemical tests were collected at V2. A subsample of V2 partici-
pants was selected as probands for the third screening, the family study (FS).
From the probands and their spouses and first-degree relatives, sociodemo-
graphic and anthropometric data, lipid-lipoprotein levels, and some ancillary
biochemical data were collected at FS.
The present analysis is confined to a subset of the total FS sample and
comprises whites of the random sample and those selected via probands with
total cholesterol above the ninetieth percentile for age and sex. In both sam-
ples, families with one or more members with triglycerides above the ninetieth
percentile for age and sex were excluded from all analyses to reduce
heterogeneity due to low HDL-C levels secondary to elevated triglyceride
levels (Borecki et al. 1986). In addition, we chose a low-HDL-C sample from
the random sample by selecting all families in which at least one member had
HDL below the tenth percentile for age and sex. Subjects who were nonfasting,
pregnant, or on lipid-altering medications at the time of the screening were
excluded from all analyses because of the effects of these conditions on the
traits under investigation. The families were generally small in size (average
approximate family size being four) and the majority were nuclear families. In
the three-generation families, the proband appeared in the middle generation.
These families were split so that the proband appeared as a parent in one
nuclear family and was duplicated as a child in another nuclear family.
There were 1,146 families with 4,279 members in the random sample, 483
families with 1,807 members in the high-cholesterol sample, and 177 families
with 735 members in the low-HDL-C sample.
Statistical Methods
Transformations and covariate adjustments.-Since the distribution of
HDL-C was skewed, values were transformed logarithmically and adjusted for
the effects of covariates as previously described (Green et al. 1984). In brief,
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after testing for and ruling out clinic-age interactions in the random-sample
families, the best-fitting piecewise cubic-regression model with an additive
clinic term was found for each sex-gonadal hormone-use group in the random
sample. The residuals from this model were squared and regressed again on the
covariates. The values predicted by this model gave the predicted variance. To
remove the possible effects of the covariates on the variance of the traits, the
original residuals were divided by the square root of the predicted variances.
This procedure also standardized the trait values to mean zero and variance
unity within each age-sex-hormone group in the random sample. The parameter
estimates from the random sample were used to adjust the values of the high-
cholesterol sample.
Segregation models.-Segregation analyses were performed on HDL-C by
means of the unified mixed model (Lalouel et al. 1983) implemented in the
computer program POINTER (Lalouel and Morton 1981; Morton et al. 1983). The
basic model postulates that a quantitative trait x can be expressed as the sum of
three independent components: g, a major effect with two determinants, A and
a, that result in three groups AA, Aa, and aa, which are indexed by 1, 2, and 3,
respectively; c, a normally distributed multifactorial transmissible effect; and
e, a normally distributed random nontransmissible effect, such that x = g + c
+ e. The major effect results in group-specific means (RI, P2, and v3 for types
AA, Aa, and aa, respectively), with variation about the means that is due to c
and e. Parameters of the model include Q, the frequency of the major determi-
nant (a) resulting in lower HDL-C; T, the displacement, = ,tl - p3; D, the
degree of dominance, = (RI - pO)IT; H, the heritability of the multifactorial
component; and Ti, i = 1, 2, 3, where Ti = Pr(parent with type i passes A to an
offspring).
The parameter estimation and tests of hypotheses were carried out by max-
imizing the likelihood of the data under a general model and also under subhy-
potheses specified by imposing constraints on the general model. Under regu-
larity conditions, twice the difference in the log likelihoods between the general
model and a subhypothesis was asymptotically distributed as a X2-variate with
df equal to the number of constraints imposed by the hypothesis.
Analyses were performed separately within the random, the high-choles-
terol, and the low-HDL-C samples. While there was no need to make any
corrections in the random sample, ascertainment corrections were needed for
the high-cholesterol and low-HDL-C samples (Elston and Sobel 1979). The
general method adopted in the mixed model, when analyzing nuclear families
selected through offspring, is to assume that each affected individual has an
equal probability of ascertainment, x, and to calculate the likelihood of the
family conditional on the sibship having been ascertained. The 'r-value was
generally estimated prior to segregation analyses and was assumed to be inde-
pendent of age and severity of the disease, and each ascertainment was consid-
ered an independent event.
A method of ascertainment correction suggested by Cannings and Thompson
(1977) was based on the following assumptions: (1) that whether a pedigree is
extended depends only on the phenotypes of individuals already observed and
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(2) that there is single ascertainment (-r -- 0). Under these conditions, correc-
tion for ascertainment is accomplished by calculating the likelihood of the
pedigrees conditional on the phenotypes of the probands. We implemented this
approach in POINTER and used it to analyze the high-cholesterol and low-HDL-C
families. The ii value has been considered to be very small when families have
been selected in a similar fashion in other analyses (Williams and Lalouel 1982),
and the number of multiple ascertainments in our sample, when compared with
its total size, was small. Moreover, we have a sizable random sample with
which to compare and assess the effects of any distortions attributable to
ascertainment correction.
RESULTS
The segregation models were initially fit to each clinic's data separately,
within each of the random and high-cholesterol samples, and a test for
heterogeneity among clinics under the mixed model (i.e., Q, D, T, and H all
estimated; T1 = 1.0, T2 = .05, T3 = .0) was performed. There was significant
heterogeneity among clinics in both samples, with primarily two or three clinics
contributing to the heterogeneity. Different clinics appeared to deviate in the
high-cholesterol and random samples. In the high-cholesterol sample, there
were two outliers with values < - 6.0. Because such values can have a dispro-
portionate effect on the analysis, we truncated the outliers to a value of - 6.0.
This reduced the heterogeneity among clinics considerably but did not entirely
remove it. In spite of the heterogeneity of the parameter estimates, however,
the conclusions from the within-clinic analyses were quite consistent. In six of
the nine clinics, both the hypothesis of no major effect and that of no multifac-
torial effect were rejected; in two clinics only the hypothesis of no multifacto-
rial effect was rejected, and in only one clinic could neither hypothesis be
rejected. To increase the power of the tests and provide a comprehensible
summary, only results from data pooled across clinics will be presented.
Random Sample
The results of analyses in the random-sample component are shown in table
1. The hypotheses of no multifactorial effect (X2 = 109.8) and of no major effect
(X2 = 57.8) were both rejected. To investigate whether the major effect repre-
sents a major gene, we tested the hypotheses that T1 = 1.0, T2 = .5, T3 = .0, and
T1 = 2 = T3, an application of the unified model (Lalouel et al. 1983). The
environmental hypothesis (T1 = T2 = T3) states that the probability of transmis-
sion of the major factor does not depend on parental type. This hypothesis was
not rejected (X22 = 2.2). The Mendelian hypothesis states that, under the mixed
model, the probability of transmission of the major factor conforms to the
expectations of Mendel's laws (TI = 1.0, T2 = .5, T3 = .0). This hypothesis was
rejected (X23 = 9.9, P < .05). The combination of these results indicates that
there exists a major factor that aggregates in families, but the distribution
within families does not conform to what would be expected of a major gene.
Because of numeric difficulties when estimating all three transmission proba-
bilities simultaneously, we also investigated a model in which T, and T3 were
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TABLE I
COMPLEX SEGREGATION ANALYSIS IN THE RANDOM SAMPLE
ESTIMATES
D T Q H T1 2 T3 X2 (df) a
No multifactorial
effect .0.47 1.86 0.440 ... ... .. 109.8*** (1)
No major effect........ . ... ... 0.562 .. . 57.8*** (3)
Mendelian mixed
model.0 ...............05 3.70 0.086 0.496 . . .. 9.9* (3)
Unrestricted model .... 0.13 3.81 0.090 0.451 1.000 0.729 1.000 ...
Environmental .........00 3.20 0.095 0.524 0.905 0.905 0.905 2.2 (2)
T2 Estimated ...........00 3.39 0.101 0.484 ... 0.672 ... 4.3 (1)
a X2 = - 2 x difference in log likelihoods between a general and a restricted model. For no multifactorial effect
and no major effect, the comparison is with the Mendelian mixed model; for the environmental model and the
Mendelian mixed model, the comparison is with the unrestricted model.
* P < .05.
*** P < .001.
fixed at 1.0 and .0, respectively, and in which T2 was estimated. This resulted in
parameter estimates quite similar to those of the Mendelian mixed models and
to an estimate of T2 slightly larger than would be expected. However, when the
hypothesis that T2 = .5 was tested (T2 being estimated vs. the Mendelian mixed
model: X21 = 4.3, P < .05), it was rejected, a result lending support to the
conclusion above.
High-Cholesterol Sample
The results of analyses in the high-cholesterol sample are shown in table 2.
Section A of the table pertains to results when ascertainment correction was
approximated by calculating likelihoods conditional on the proband's pheno-
type. The hypothesis of no multifactorial effect was rejected (X2I = 30.9, P <
.001), whereas the hypothesis of no major effect was not (X23 = 6.5, .10 < P <
.05). Since this result was borderline, we attempted to fit the unrestricted model
and test the Mendelian and environmental hypotheses. Owing to numeric
difficulties, we were unable to obtain reliable estimates for rl and T3, so these
parameters were fixed at 1.0 and .0, respectively. Although the true likelihood
for the unrestricted model would be larger-and therefore the x2-values for
testing the Mendelian and environmental hypotheses would be larger-both
these hypotheses were rejected with P < .001.
Because conditioning on the proband's phenotype may not adequately cor-
rect for ascertainment, we performed analyses on the subset of the high-
cholesterol-sample families in which the proband was a parent, calculating
likelihoods conditional on the phenotypes of both parents. The results are
shown in Section B of table 2. This restricted sample contained 190 families
with 766 offspring. As in the entire high-cholesterol sample, the hypothesis of
no multifactorial effect was rejected (X21 = 17.7, P < .001) whereas the hy-
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TABLE 2
COMPLEX SEGREGATION ANALYSIS IN THE HIGH-CHOLESTEROL SAMPLE
ESTIMATES
D T Q H TJ T2 T3 X 2(df )a
A. LIKELIHOOD CONDITIONAL ON PROBAND
No multifactorial
effect .0.52 2.07 0.607 ... . ... .. 30.9*** (1)
No major effect ..... ... ... ... 0.608 ... ... ... 6.5 (3)
Mendelian mixed
model .0.0 3.16 0.069 0.584 ... ... ... >28.4*** (3)
Unrestrictedb.0.36 0.97 0.034 0.482 1.0 1.0 0.0 ...
Environmental 0.0 3.13 0.056 0.599 0.944 0.944 0.944 >29.7*** (2)
B. LIKELIHOOD CONDITIONAL ON BOTH PARENTS
No multifactorial
effect .0.51 1.96 0.560 ... . ... ... 17.7**(1)
No major effect ..... ... ... 0.598 ... ... ... 5.8 (3)
Mendelian mixed
model .0.0 3.75 0.063 0.569 ... ... ... 2.1 (1)
Unrestrictedb.0.20 2.38 0.159 0.430 1.0 0.779 0.0 ...
Environmental. 0.02 3.72 0.055 0.584 0.945 0.945 0.945 ...
aX2 2 x difference in log likelihoods between a general and a restricted model. For no multifactorial effect
and no major effect, the comparison is with the Mendelian mixed model; for the environmental model and the
Mendelian mixed model, the comparison is with the unrestricted model.
b Numeric difficulties were experienced when estimating all Tr. Therefore, Tj was fixed at 1.0 and T3 was fixed at
.0. The "true" log likelihood for the unrestricted model will be larger, so the x2 values for the Mendelian and
environmental models are greater than indicated.
P**p < .001.
pothesis of no major effect was not (X23 = 5.8, P = .10). Parameter estimates
were quite similar. As before, numeric problems prevented estimation of T1 and
T3. The hypothesis that T2 = .5 was not rejected (X21 = 2.1, P > .10). The
environmental hypothesis cannot be formally tested, but the Mendelian mixed
model is - 1.28 times as likely as the model with T1 = T2 = T3. These results are
qualitatively similar to those in the entire high-cholesterol sample but are based
on a sample with a smaller amount of information. Correcting for ascertainment
by conditioning on the proband's phenotype is probably adequate in these data
and results in using more of the available information.
Low-HDL-C Sample
To reduce potential heterogeneity-and to identify a group of families that
were more likely to be segregating a major gene for low HDL-C, if one exists-
we used the random sample as a base and selected all families in which at least
one member had HDL-C below the tenth percentile after adjusting for age and
sex. There was one individual with an extremely low HDL-C value who ap-




COMPLEX SEGREGATION ANALYSIS IN THE Low-HDL COMPONENT OF THE RANDOM SAMPLE
ESTIMATES
D T Q H Ti T2 T3 X2(df) a
No multifactorial
effect .............. 1.04 0.248 ... ... ... ... 14.2*** (1)
No major effect ..... ... ... ... 0.278 ... ... ... 9.5* (3)
Mendelian mixed
model . ............0. 3.92 0.028 0.302 .. . ... >14.0** (3)
Unrestrictedb.........41 2.04 0.104 0.0 1.0 1.0 0.0 ...
Environmental 0.......16 3.06 0.101 0.503 0.877 0.877 0.877 >14.6*** (2)
aX2 = - 2 x difference in log likelihoods between a general and a restricted model. For no multifactorial effect
and no major effect, the comparison is with the Mendelian mixed model; for the environmental model and the
Mendelian mixed model, the comparison is with the unrestricted model.
b Numeric difficulties were experienced when estimating all rTi. Therefore, T. was fixed at 1.0 and T3 was fixed at
.0. The "true" log likelihood for the unrestricted model will be larger, so the x2 values for the Mendelian and
environmental models are greater than indicated.
* P < .05.
** P < .01.
*** P < .001.
suited in considerable numeric difficulties. This individual was excluded from
these analyses, resulting in a sample of 177 families ascertained through an
individual with HDL-C below the tenth percentile. All likelihoods are condi-
tional on the proband's phenotype. Results are shown in table 3. The hypoth-
eses of no multifactorial effect (X21 = 14.2, P < .001) and of no major effect (X23
= 9.5, P < .05) were both rejected. Again, estimation of TI and T3 proved
unreliable, so these parameters were fixed at 1.0 and .0, respectively. In spite
of this difficulty, both the Mendelian mixed-model hypothesis (X23 > 14.0, P <
.001) and the environmental hypothesis (X22 > 14.6, P < .001) were rejected.
These results indicate the presence of (1) a major factor that does not segregate
like a gene but is transmitted from parent to offspring and (2) multifactorial
effects.
DISCUSSION
Low HDL-C levels are of clinical importance because of the well-established
inverse relationship with coronary heart disease (Miller and Miller 1975; Cas-
telli et al. 1977; Gordon et al. 1977; Goldbourt and Medalie 1979). The delinea-
tion of a subtype of familial hypoalphalipoproteinemia that is influenced by a
single major locus would have implications for screening and intervention pro-
grams, as well as for basic research. Recently, Ordovas et al. (1986) have
demonstrated a DNA restriction-fragment-length polymorphism in the apoA-I,
apoC-Il, apoA-IV gene complex following PstI digestion. The allele frequency
of this polymorphism was 2% in control subjects and 41.7% in index cases of
kindreds with familial hypoalphalipoproteinemia. Bottom-decile HDL-C was
present in 73% of subjects who were heterozygous or homozygous for the
polymorphism. This polymorphism appears to be associated with one of the
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causes of genetic HDL deficiency (Byard et al. 1984; Third et al. 1984; Borecki
et al. 1986) that results in premature coronary artery disease (Ordovas et al.
1986). Rees et al. (1983) have demonstrated a polymorphism adjacent to the 3'
flanking region of the human apoA-I gene following Sacl digestion; this poly-
morphism is primarily related to hypertriglyceridemia in subjects who also
have concurrent depressions of HDL-C. Since the common PstI polymorphism
is associated with familial hypoalphalipoproteinemia and coronary heart dis-
ease (Ordovas et al. 1986), the observation of a single major locus for low HDL-
C may have considerable importance in better definition of a risk factor associ-
ated with premature coronary heart disease and stroke (Daniels et al. 1982;
Glueck et al. 1982; Norum et al. 1982; Byard et al. 1984; Third et al. 1984;
Borecki et al. 1986).
Our analyses suggest the presence of a major factor resulting in two compo-
nents of the HDL-C distribution. This factor is transmitted from parent to
offspring, but we are unable to conclude that the "factor" segregates as a gene.
This result is fairly consistent across samples, although in the random sample
the hypothesis of no transmission is not rejected and holds when different
approaches to ascertainment correction are used. Parameter estimates are
fairly consistent in different analyses and result in a model of the HDL-C
distribution that is a mixture of two components, with means separated by -3
SD and one-third to one-half of the variation in HDL-C levels being due to
multifactorial effects.
We experienced considerable numeric difficulties in the analysis of these
data, particularly in models in which transmission probabilities were estimated.
Either transmission probabilities or Q frequently converged to a bound, a situa-
tion that resulted in the remaining parameters perhaps not being at their true
maximum-likelihood estimates. In other cases, very slight changes in a parame-
ter value caused large differences in likelihoods. The difficulties in estimating
transmission probabilities under the unified model may have a number of
causes, including (1) etiological heterogeneity among subsets of the data and (2)
inadequate data for estimating the parameters.
We used several approaches to try to reduce heterogeneity. In all analyses,
families with high triglyceride levels were excluded because of the association
between these traits (Malloy and Kane 1982; Byard et al. 1984; Third et al.
1984; Borecki et al. 1986). We also selected a subsample of the random sample
in which the proband had low HDL-C. Similar analyses were not carried out in
a subset of the high-cholesterol sample because there were very few such
families with low HDL-C.
The data set consisted of small nuclear families, and in many cases no data
on HDL-C was available for one or both parents. Under these conditions,
estimation of transmission probabilities is difficult, particularly when the fre-
quency of the major factor is small. Estimation of T2 only, with T and T3 fixed at
1.0 and .0, respectively, has been suggested as a possible approach (Lalouel et
al. 1983), which we used in the face of the numeric problems. However, results
of simulation studies (Demenais et al. 1986) suggest that tests based on T2 alone
may not protect against falsely inferring the presence of a major gene.
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The behavior of segregation models, as assessed in simulated data (MacLean
et al. 1975; Go et al. 1978; Eaves 1983; MacCleur et al. 1983), previously
published analyses (Morton et al, 1978), and the present analysis, suggests
caution in the interpretation of results. Skewness of the data values can result
in spurious detection of a major locus (Eaves 1983; MacCleur et al. 1983).
Eaves (1983) used data simulated under a polygenic model yet found that the
mixed model fit significantly better than the pure polygenic model in five of 10
data sets, even when transmission probabilities were estimated. When
skewness was negligible, significant kurtosis led to the detection of a spurious
major locus.
In our data, the scores had skewness and kurtosis of -0.36 and 4.33, respec-
tively, in the random sample. We also transformed these scores to a scale on
which a random sample is normalized, as follows: The whites from the V2
random sample (6,675 subjects) were used as the reference group. The ad-
justed, standardized values were ranked, and normal scores were defined as
4- '(s), where 4 is the standard normal cumulative distribution function and s is
the ratio of the rank to total sample size plus one. To transform our HDL-C
scores to the same scale, they were superimposed on those of the V2 reference
group and assigned normalized scores that were nearest to the corresponding
reference-group value. The normal scores had coefficients of skewness and
kurtosis of - 0.04 and 2.91, respectively, in the random sample, values not
significantly different from values expected from a normal distribution. Analy-
sis of the normal scores showed some differences from the analysis of standard-
ized scores presented here, primarily in parameter estimates. In the random
sample and the high-cholesterol sample, the mixed model fit significantly better
than either the model with no multifactorial effect or the model with no major
effect. But some of the parameter estimates were considerably different; for
example, in the random sample, T was much smaller and Q was much larger
when analyzing the normal scores and, in the high-cholesterol sample, T was
much larger and H was somewhat smaller when analyzing the normal scores.
These results are qualitatively similar to those of analyses of the standardized
scores. Since if there is a major effect present in the population the distribution
will be an admixture and therefore skewed, the use of scores that force a
normal distribution in the population may tend to obscure evidence of a major
effect, regardless of whether it is a gene. The major effect detected is probably
not an artifact of nonnormal skewness or kurtosis.
Another possible source of difficulty is the ascertainment correction used in
the analysis of the high-cholesterol sample. The method of analyzing the data
conditional on the probands' values is a valid approximation only in the limiting
case of single ascertainment (Cannings and Thompson 1977). Since several of
the families were ascertained through more than one proband, this may not be a
reasonable assumption. In the high-cholesterol sample, similar results were
obtained both conditioning on the probands' values and in the subset of families
in whom the proband was a parent conditioning on the values of both parents.
A further complication is that ascertainment was based on total cholesterol
rather than on HDL-C. Methods for constructing the likelihood for data ascer-
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tained in this way have been described (Dawson and Elston 1984) but have not
been incorporated into currently available software. Because the correlation
between total cholesterol and HDL-C is modest (Heuch et al. 1985), it may not
be critical to use any ascertainment corrections in the high-cholesterol sample.
Keeping these analytical reservations in mind, segregation analysis of this
large, population-based data set supports the hypothesis that there exists a
major factor that affects the distribution of HDL-C and results in a subgroup of
individuals with low HDL-C. Although the factor does not appear to segregate
like a major gene, it aggregates within families and is transmitted parent to
offspring. This observation, coupled with the association of low HDL-C with a
common polymorphism (Ordovas et al. 1986), should emphasize the diagnostic
importance of heritable depressions of HDL-C-and stimulate studies de-
signed to ameliorate hypoalphalipoproteinemia, with the goal of preventing
coronary heart disease (Glueck 1985).
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